This study is testing if a short, focused radiation treatment called Stereotactic Body Radiotherapy (SBRT) Boost is a safe and effective way to treat prostate cancer. This SBRT boost delivers a high dose of radiation to the prostate without needles, similar to another treatment called HDR brachytherapy. The study wants to see how well this treatment controls the cancer and what side effects it might cause, as well as how it affects your quality of life. You may be able to join if you are an adult man with prostate cancer that has been confirmed by a biopsy. The main goal is to measure the rate of severe stomach or urinary side effects after 5 years. The current recruitment status is unclear.

Study design

This is an interventional study planning to enroll 150 participants. It is designed to evaluate the SBRT boost as a replacement for traditional HDR brachytherapy.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 5 years to track side effects, PSA response, and quality-of-life outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.